It’s all About Construction
Valeant’s Canadian Patent No. 2,524,300 claims a modified-release bupropion tablet with three parts: a core comprising the active ingredient and various excipients;...Read More
Technical complexity a lion in the path of NEXIUM obviousness challenge
Om March 5, 2013, Justice O’Keefe of the Federal Court of Canada released Reasons for Judgment in a prohibition application involving Ranbaxy...Read More